Ashford Hospitality’s Stock Breaks Through Resistance: What’s Next?
Ashford Hospitality Trust Inc. (NYSE: AHT) is trading higher Friday morning as retail traders have been able to continue to push the stock up.
3 Penny Stocks To Consider For The Oil Rally
As oil continues to soar and approaches $70 a barrel, shares of many stocks in the energy sector have rallied as well. Some appear to be poised to keep moving higher.
Cyclerion Out-Licenses Praliciguat to Akebia, Announces $18M Capital Raise
Cyclerion Therapeutics Inc (NASDAQ:CYCN) has entered into an exclusive, global license agreement with Akebia Therapeutics Inc (NASDAQ:AKBA) for the development and commercialization of…
Surface Oncology’s SRF388 Shows Promising Anticancer Activity in Pretreated Patients
Surface Oncology (NASDAQ:SURF) has announced new data from the ongoing Phase 1 studies of SRF388 and SRF617. SRF388 data will be…
Mid-Morning Market Update: Markets Open Higher; US Economy Adds 559,000 Jobs in May
Following the market opening Friday, the Dow traded up 0.26% to 34,666.18 while the NASDAQ rose 1.22% to 13,780.27. The S&P also rose, gaining 0.64% to 4,219.82.
Surface Oncology, Roche Team Up to Develop SRF388 Combo Therapy for Liver Cancer
Surface Oncology (NASDAQ:SURF) has entered into a clinical trial collaboration with Roche Holdings AG (OTC:RHHBY) to evaluate former’s SRF388, anti-IL-27 antibody, in combination…
Coherus, Junshi Toripalimab-Chemo Combo Beat Chemo Alone in Late-Stage Nose & Throat Cancer Trial
Shanghai Junshi Biosciences Co Ltd and Coherus BioSciences Inc (NASDAQ:CHRS) have announced positive results from the pivotal Phase 3 JUPITER-02 trial evaluating toripalimab…
The Daily Biotech Pulse: Merck, AstraZeneca, Novartis Among Early Presenters At ASCO, Sanofi Strikes Breast Cancer Study Pact
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 3)
Nanobiotix’s Nanoparticle Technology Shows Tumor-Killing Effect in Early-Stage Head & Neck Cancer
Nanobiotix (NASDAQ:NBTX), ahead of the 2021 Annual Meeting of the American Society for Clinical Oncology meeting, has said that…
Is Now The Time To Buy Stock Or Options In Wells Fargo, Workhorse Or AMC?
One of the most common questions traders have about stocks is “Why Is It Moving?”
That’s why Benzinga created the Why Is It Moving, or WIIM, feature in Benzinga Pro. WIIMs are a one-sentence description as to why that stock is moving.